{{Rsnum
|rsid=2272522
|Gene=CHL1
|Chromosome=3
|position=319825
|Orientation=plus
|GMAF=0.3108
|Gene_s=CHL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 60.7 | 35.7 | 3.6
| HCB | 44.1 | 41.2 | 14.7
| JPT | 57.3 | 36.4 | 6.4
| YRI | 13.7 | 48.6 | 37.7
| ASW | 26.3 | 45.6 | 28.1
| CHB | 44.1 | 41.2 | 14.7
| CHD | 44.9 | 43.9 | 11.2
| GIH | 39.8 | 53.1 | 7.1
| LWK | 18.2 | 52.7 | 29.1
| MEX | 67.9 | 25.0 | 7.1
| MKK | 23.5 | 53.6 | 22.9
| TSI | 67.6 | 29.4 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23857787
|Title=Significant association of close homologue of L1 gene polymorphism rs2272522 with schizophrenia in Qatar
}}

{{PMID Auto
|PMID=15653271
|Title=Case-control association study of the close homologue of L1 (CHL1) gene and schizophrenia in the Chinese population.
}}

{{PMID Auto
|PMID=19875614
|Title=A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}